Plain-English translation of NCT06409052 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is asking women about their views, concerns, and ideas regarding uterine cancer and ways to prevent it. The study includes three groups: women who have been diagnosed with uterine cancer, women who have precancerous changes or abnormal bleeding in the uterus, and women who do not have either condition. By listening to what matters most to patients and at-risk women, researchers hope to develop better prevention strategies and communication approaches.
Uterine cancer affects many women, and understanding their real-world perspectives on risk factors and prevention can help doctors create more effective and patient-centered prevention plans. This research fills an important gap by centering patient and community voices in the conversation about preventing this disease.
You likely qualify if…
You likely don't qualify if…
This is a research study focused on gathering your thoughts and experiences rather than testing a medication or procedure. You would likely participate in interviews or complete surveys about your views on uterine cancer, risk factors, and prevention strategies. The study is currently recruiting 45 women and is based at MD Anderson Cancer Center in Houston.
AI-generated summary from trial data · Jun 28, 2026 · Not medical advice
United States
Enrollment target
~45 participants
Started
June 2024
Primary completion
August 2026
Age range
18 Years and older
Sex
Female only
Last updated on clinicaltrials.gov in July 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Larissa Meyer, MD
M.D. Anderson Cancer Center
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.